146 related articles for article (PubMed ID: 37808937)
1. Diversity of
Amini Khiabani S; Haghighat S; Tayebi Khosroshahi H; Asgharzadeh M; Samadi Kafil H
Health Promot Perspect; 2023; 13(3):237-242. PubMed ID: 37808937
[TBL] [Abstract][Full Text] [Related]
2. Clostridium species diversity in gut microbiota of patients with renal failure.
Khiabani SA; Haghighat S; Khosroshahi HT; Asgharzadeh M; Kafil HS
Microb Pathog; 2022 Aug; 169():105667. PubMed ID: 35793779
[TBL] [Abstract][Full Text] [Related]
3.
Hanifi GR; Samadi Kafil H; Tayebi Khosroshahi H; Shapouri R; Asgharzadeh M
Arch Razi Inst; 2021; 76(3):521-528. PubMed ID: 34824745
[No Abstract] [Full Text] [Related]
4. Uremic Toxin-Producing
Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY
Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102
[TBL] [Abstract][Full Text] [Related]
5. Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages.
Li J; Xing H; Lin W; Yu H; Yang B; Jiang C; Zhang J; Wu R; Ding F; Pei M; Yang H
Front Med (Lausanne); 2023; 10():1302352. PubMed ID: 38249961
[TBL] [Abstract][Full Text] [Related]
6. Changes in the Intestinal Microbiota in Patients with Stage 5 Chronic Kidney Disease on a Low-Protein Diet and the Effects of Human to Rat Fecal Microbiota Transplantation.
Jiang S; Wang B; Sha T; Li X
Med Sci Monit; 2020 Jun; 26():e921557. PubMed ID: 32592577
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
8. Fecal microbiota transplantation restores normal fecal composition and delays malignant development of mild chronic kidney disease in rats.
Liu X; Zhang M; Wang X; Liu P; Wang L; Li Y; Wang X; Ren F
Front Microbiol; 2022; 13():1037257. PubMed ID: 36532422
[TBL] [Abstract][Full Text] [Related]
9. High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.
Hu J; Zhong X; Yan J; Zhou D; Qin D; Xiao X; Zheng Y; Liu Y
BMC Nephrol; 2020 Jan; 21(1):12. PubMed ID: 31931722
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease.
Chen R; Zhu D; Yang R; Wu Z; Xu N; Chen F; Zhang S; Chen H; Li M; Hou K
Ann Transl Med; 2022 Jul; 10(13):750. PubMed ID: 35957707
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.
Luo D; Zhao W; Lin Z; Wu J; Lin H; Li Y; Song J; Zhang J; Peng H
Front Cell Infect Microbiol; 2021; 11():579386. PubMed ID: 33834002
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes-A Systematic Review.
Voroneanu L; Burlacu A; Brinza C; Covic A; Balan GG; Nistor I; Popa C; Hogas S; Covic A
J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902734
[TBL] [Abstract][Full Text] [Related]
13. [Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors].
Bao WH; Tang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):124-132. PubMed ID: 36718700
[TBL] [Abstract][Full Text] [Related]
14. Correlation of inflammatory biomarkers with the diversity of Bacteroidaceae, Bifidobacteriaceae, Prevotellaceae and Lactobacillaceae families in the intestinal microbiota of patients with end stage renal disease.
Asgharian M; Gholizadeh P; Samadi Kafil H; Ghojazadeh M; Samadi A; Soleymani J; Jouyban A; Tayebi Khosroshahi H
Adv Med Sci; 2022 Sep; 67(2):304-310. PubMed ID: 35994929
[TBL] [Abstract][Full Text] [Related]
15. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
[TBL] [Abstract][Full Text] [Related]
16. Alterations of gut microbes and their correlation with clinical features in middle and end-stages chronic kidney disease.
Chen H; Wang J; Ouyang Q; Peng X; Yu Z; Wang J; Huang J
Front Cell Infect Microbiol; 2023; 13():1105366. PubMed ID: 37033494
[TBL] [Abstract][Full Text] [Related]
17. Different
Kollarcikova M; Faldynova M; Matiasovicova J; Jahodarova E; Kubasova T; Seidlerova Z; Babak V; Videnska P; Cizek A; Rychlik I
Microorganisms; 2020 Sep; 8(10):. PubMed ID: 32992519
[TBL] [Abstract][Full Text] [Related]
18. Bacteroides barnesiae sp. nov., Bacteroides salanitronis sp. nov. and Bacteroides gallinarum sp. nov., isolated from chicken caecum.
Lan PTN; Sakamoto M; Sakata S; Benno Y
Int J Syst Evol Microbiol; 2006 Dec; 56(Pt 12):2853-2859. PubMed ID: 17158987
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
[No Abstract] [Full Text] [Related]
20. Gut dysbiosis-influence on amygdala-based functional activity in patients with end stage renal disease: a preliminary study.
Zheng LJ; Lin L; Zhong J; Zhang Z; Ye YB; Zhang XY; Wang YF; Zhang H; Liu Y; Lu GM; Gong D; Zhang LJ
Brain Imaging Behav; 2020 Dec; 14(6):2731-2744. PubMed ID: 32304020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
